Gland Pharma Q3 results: Company reports Rs 192 crore profit after tax
The results for the quarter under review and the nine months of the current fiscal are not comparable to the earlier periods of the previous year due to the inclusion of Cenexi results, the Hyderabad-based company said.
The company's revenue from operations stood at Rs 1,545 crore for the October-December period, up from Rs 938 a year ago. Image Courtesy: Reuters.